Logo
x

Search category

Subscribe Now

Tryp Therapeutics

Tryp Therapeutics Reports the First Patient Dosing with TRP-8802 in P-IIa Clinical Trial for the Treatment of Fibromyalgia

Tryp Therapeutics Reports the First Patient Dosing with TRP-8802 in P-IIa Clinical Trial for the Treatment of Fibromyalgia

  • January 5, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.